Healthcare -
Biotechnology - NASDAQ - GB
$ 0.5938
-2.5 %
$ 152 M
Market Cap
-3.49
P/E
ADAP - DEPRECIATION & AMORTIZATION
Depreciation & Amortization ADAP - Adaptimmune Therapeutics plc
9.45 M
LAST VALUE
19.98%
2 YEAR CAGR
3.89%
5 YEAR CAGR
70.47%
10 YEAR CAGR